Last updated
PTC Therapeutics: Product Launch
Global Sephience (sepiapterin) launch showing strong momentum with $125M Q1 revenue and 36% quarter-over-quarter growth, supporting full-year guidance raise
Source: PRN — Real Estate
The leadership read
Product momentum tends to widen the sector product and commercial leadership bench strength.
Market context: MitchelLake's Talent Market Index sits at 112.9 (Hot), up 11.4 on the prior month; EMEA hiring signal is running easing (-3.2pts).
PTC Therapeutics: 1 signal in the last 90 days; 0.1% of MitchelLake's EMEA signal flow.
MitchelLake in this thematic
More signals across EMEA
Product Launch · EMEA
Siteimprove →Siteimprove launched a new MCP (Model Context Protocol) Server that integrates accessibility capabilities into AI workflows across Lovable, Anthropic Claude, VS Code, and Figma, enabling automated accessibility in digital experience creation.
Product Launch · EMEA
ST Engineering →ST Engineering secured a US$87.1 million UK defence contract to provide nine variants of 40mm high and low velocity grenades to the military.
Product Launch · EMEA
CSL →CSL's Tavenos product faced a regulatory setback in the European Union, flagged as a potential challenge to the biotechnology major
Product Launch · EMEA
JFrog →JFrog is gaining analyst momentum for AI-focused tools and software supply chain security offerings, with strong traction in managing AI development workflows and securing cloud-native software pipelines.
Product Launch · EMEA
Globant →Globant introduced AI Pods-powered Synthetic Operator for automated live-stream monitoring, targeting mission-critical media workflows with agentic AI tools.
Product Launch · EMEA
MSD →MSD's pembrolizumab received NICE recommendation for locally advanced cervical cancer (LACC), representing first immunotherapy approval in this indication in England
Intelligence powered by Autonodal ↗